ACPA production tends to be associated with a more aggressive course,[20] however, other prognostic markers could be involved in RA phenotypes.[21] New biomarkers for RA disease phenotypes, joint outcomes, and severity may be useful to predict the therapeutic outcomes in RA patients. Here, PRTN3 is linked to rheumatoid arthritis.